From: Prediction of mortality using a multi-bed vascular calcification score in the Diabetes Heart Study
 | Mean ± SD or % | Median (range) |
---|---|---|
Demographic information | ||
Age (years) | 62.8 ± 8.6 | 63.1 (40–86) |
Gender (% female) | 50.2% | Â |
Diabetes duration (years) | 10.3 ± 7.1 | 8 (0–46) |
% smoking (current or past) | 59.9% | Â |
Self-reported history of prior CVD (%) | 43.8% | Â |
Deceased (%) | 22.3% | Â |
Deceased from CVD (%) | 10.6% | Â |
Body composition | ||
Height (cm) | 168.7 ± 9.6 | 168.7 (122.8-195.4) |
Weight (kg) | 92.0 ± 19.6 | 89.5 (40.8-158.8) |
BMI (kg/m2) | 32.2 ± 6.2 | 31.3 (17.1-55.6) |
Medications | ||
Oral hypoglycemic agents | 80.0% | Â |
Lipid lowering (%) | 52.9% | Â |
Anti-hypertensive (%) | 74.5% | Â |
Blood pressure (BP) | ||
Systolic BP (mmHg) | 139 ± 18 | 138 (94–214) |
Diastolic BP (mmHg) | 72 ± 10 | 72 (37–106) |
Hypertension (%) | 87.8% | Â |
Blood biochemistry | ||
Glucose (mg/dL) | 146.3 ± 53.7 | 135 (16–463) |
Hemoglobin A1C (%) | 7.4 ± 1.4 | 7.1 (4.6-16.6) |
Hemoglobin A1C (mmol/mol) | 57.0 ± 15.7 | 54.1 (26.8-157.9) |
Total Cholesterol (mg/ dL) | 183.6 ± 42.0 | 180 (65–391) |
High density lipoprotein cholesterol (mg/dL) | 42.7 ± 12.1 | 41 (8–98) |
Low density lipoprotein cholesterol (mg/dL) | 102.5 ± 32.2 | 100 (12–236) |
Triglycerides (mg/dL) | 198.6 ± 124.3 | 170 (30–1068) |
Vascular imaging | ||
Coronary artery calcified plaque | 1893 ± 3515 | 420 (0–50415) |
Carotid artery calcified plaque | 346 ± 705 | 56 (0–5954) |
Abdominal aortic calcified plaque | 12113 ± 16353 | 4561 (0–94156) |
Multi-bed score | 1.95 ± 2.71 | 0.86 (0–23.57) |